Stockscreener 앱 받기
16.25
0.06%
-0.01
시간 외 거래:
16.25
전일 마감가:
$16.26
열려 있는:
$16.01
하루 거래량:
881
Relative Volume:
0.27
시가총액:
$392.94M
수익:
$6.41M
순이익/손실:
$31.54M
주가수익비율:
9.20
EPS:
1.7663
순현금흐름:
$-100.78M
1주 성능:
-3.62%
1개월 성능:
-10.12%
6개월 성능:
+0.31%
1년 성능:
-8.89%
1일 변동 폭
$16.00
$16.26
1주일 범위
$16.00
$16.90
52주 변동 폭
$13.30
$20.00
Puretech Health Plc Adr Stock (PRTC) Company Profile
Compare PRTC vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRTC
Puretech Health Plc Adr
|
16.25 | 393.18M | 6.41M | 31.54M | -100.78M | 1.7663 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Puretech Health Plc Adr Stock (PRTC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-09-09 | 재개 | Leerink Partners | Outperform |
Puretech Health Plc Adr 주식(PRTC)의 최신 뉴스
Lansdowne Partners UK LLP Takes Position in PureTech Health PLC Sponsored ADR $PRTC - MarketBeat
PureTech Health PLC Sponsored ADR (NASDAQ:PRTC) Short Interest Up 36.2% in February - MarketBeat
PureTech to Present at the Leerink Partners Global Healthcare Conference - ChartMill
PureTech Health PLC Sponsored ADR (NASDAQ:PRTC) Short Interest Update - MarketBeat
Idiopathic Pulmonary Fibrosis Clinical Trials & Pipeline Overview: Insights into 80+ Leading Companies and 100+ Novel Treatments | DelveInsight - GlobeNewswire Inc.
PureTech Health (NASDAQ:PRTC) Shares Up 2%Here's Why - MarketBeat
PRTC Stock Price and Chart — NASDAQ:PRTC - TradingView — Track All Markets
PureTech Health (NASDAQ:PRTC) Trading Up 5.7%Here's Why - MarketBeat
PureTech Health (NASDAQ:PRTC) Trading Up 5.7% – Here’s Why - Defense World
PureTech CEO to present at J.P. Morgan Healthcare Conference By Investing.com - Investing.com India
PureTech CEO to present at J.P. Morgan Healthcare Conference - Investing.com
PureTech to Present at 44th Annual J.P. Morgan Healthcare Conference - Chartmill
PureTech Health plc (OTCMKTS:PTCHF) Sees Significant Decrease in Short Interest - Defense World
PureTech Health appoints Robert Lyne as permanent CEO - Investing.com
PureTech Health appoints Robert Lyne as permanent CEO By Investing.com - Investing.com India
PureTech Health (NASDAQ:PRTC) Trading Down 0.7% – Time to Sell? - Defense World
PureTech Health (NASDAQ:PRTC) Trading Down 0.7%Time to Sell? - MarketBeat
PureTech provides update on AGM results following shareholder concerns - Investing.com
PureTech stock falls after FDA meeting on IPF drug - Investing.com
PureTech Health (NASDAQ:PRTC) Trading 0.4% HigherStill a Buy? - MarketBeat
PureTech Health (NASDAQ:PRTC) Stock Price Up 3.1%Time to Buy? - MarketBeat
PureTech Health PLC Sponsored ADR $PRTC Shares Sold by Birch Hill Investment Advisors LLC - MarketBeat
PureTech Health PLC Sponsored ADR (NASDAQ:PRTC) Short Interest Up 100.0% in September - MarketBeat
Free cash flow per share of PureTech Health PLC Sponsored ADR – NASDAQ:PRTC - TradingView
PureTech Health (NASDAQ:PRTC) Trading Up 3.6%Here's What Happened - MarketBeat
PureTech Health PLC Sponsored ADR (NASDAQ:PRTC) Sees Significant Growth in Short Interest - MarketBeat
PureTech Health (LON:PRTC) Shares Up 14.2% – Should You Buy? - Defense World
PureTech Health Sees Strong Market Presence in FTSE All Share - Kalkine Media
Parallel Advisors LLC Acquires 1,718 Shares of GSK PLC Sponsored ADR $GSK - Defense World
What Makes PureTech Health (PRTC) a New Buy Stock - Yahoo Finance
PureTech Health PLC Sponsored ADR (NASDAQ:PRTC) Sees Large Growth in Short Interest - MarketBeat
BioHarvest Sciences (BHST) Short Interest & Short Float | Updated Dec 2025 - MarketBeat
PureTech Health (NASDAQ:PRTC) Trading Up 4.7%What's Next? - MarketBeat
International Flavors & Fragrances (NYSE:IFF) & DAQO New Energy (NYSE:DQ) Critical Comparison - Defense World
PureTech launches new entity to advance IPF treatment deupirfenidone - Investing.com
PureTech Health to report half-yearly results on August 28 - Investing.com
PureTech Health names Robert Lyne as interim CEO as Chowrira departs - Investing.com
PureTech Health announces board leadership transition - Investing.com
PureTech Health announces RSU vesting and share transactions by PDMR - Investing.com
Citius Oncology (CTOR) Short Interest & Short Float | Updated Dec 2025 - MarketBeat
TuHURA Biosciences (HURA) Short Interest & Short Float | Updated Nov 2025 - MarketBeat
Nordic Capital XI ends pursuit of PureTech acquisition - Investing.com
PureTech Health (LSE: PRTC) Presents Promising Phase 1b Data for LYT-200 in AML and MDS at ASH 2024 - Kalkine Media
India Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
Argentina Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
Norway Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
Sweden Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
Japan Anti-obesity Medication Market Size & Outlook, 2030 - Grand View Research
Mexico Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
Asia Pacific Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
Europe Anti-obesity Medication Market Size & Outlook, 2030 - Grand View Research
Puretech Health Plc Adr (PRTC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):